Tel. +34 913303000 (Ext. 483391)
Institute of Neurosciences. San Carlos Clinical Hospital.
C/ Profesor Martín Lagos s/n. 28040 Madrid
The team has been working on a multidisciplinary basis since the late 1970s. It was initially made up of specialists from the Psychiatry, Neurophysiology, Nuclear Medicine, and Endocrinology Departments of the Hospital Clínico San Carlos, with a common interest in Neuroscience. Over time, the group has been structured and has grown with the participation of physicians from the Neurology and Geriatrics Departments. The result has been an extensive clinical, teaching, and research activity in different pathologies in this field, with the first publications appearing in 1979. Since 2000 the team has had a Molecular Genetics Research Laboratory within the Research Unit of the Hospital Clínico San Carlos and since the beginning of 2010 the Head of the Magnetoencephalography Centre of the Polytechnic University of Madrid has joined the group, thus responding to the current need to incorporate new technologies in the field of neuroimaging and genetics in our multidisciplinary line of research. Our activity is based on the two lines of research that we carry out:
Dr. Alberto Marcos Dolado holds a Licentiate degree in Medicine and Surgery at the Complutense University of Madrid in 1988, obtained his doctorate in 2000 from the UCM, and has been an Associate Professor at the UCM since 2001.
Area medical specialist of the Hospital Clínico San Carlos since 1995, Vice-President of its IECm and member of the Regional IECm of the Community of Madrid.
Member of the Spanish Society of Neurology and its study groups on Dementias and Cerebrovascular Diseases.
Project evaluator for the Fondo de Investigaciones Sanitarias, external reviewer for the Revista de Neurología and member of the Editorial Committee of Neurología (Barcelona).
He has published more than 50 articles, 30 book chapters, 100 lectures and 200 national and international conference papers, mainly on Alzheimer’s disease and other dementias. She has several funded projects on early diagnosis of Alzheimer’s disease, currently a European H2020 project on biomarkers in the early detection of Alzheimer’s disease, with lines of research focusing on polygenic inheritance and neuropsychological and ophthalmological markers, structural neuroimaging, and connectivity by MEG and Magnetic Resonance Imaging with DTI and the influence of lifestyle and diet on the risk of developing Alzheimer’s dementia in first-degree relatives of patients with late forms.